Anticancer Potential and Other Therapeutic Activities of Curcumin & Its Derivatives

Year : 2026 | Volume : 03 | Issue : 01 | Page : 19 28
    By

    Rajiv Kumar,

  • Rajan Salwan.,

  • Nitish Sharma,

  • Arshdeep Singh,

  • Diksha Kumari,

  • Rajbir Singh,

  • mukesh chander,

  1. Assistant Professor,, Department of Pharmacy, School of Pharmaceutical and Allied Health Sciences, Khalsa University,, Amritsar, Punjab, India
  2. Assistant Professor, Department of Pharmacy, School of Pharmaceutical and Allied Health Sciences, Khalsa University,., Amritsar, Punjab, India
  3. Assistant Professor,, Department of Pharmacology, School of Pharmaceutical and Allied Health Sciences, Khalsa University,, Amritsar, Punjab., India
  4. Assistant Professor,, Department of Pharmacy, School of Pharmaceutical and Allied Health Sciences, Khalsa University, , Amritsar, Punjab., India
  5. Assistant Professor,, Department of Pharmacology, School of Pharmaceutical and Allied Health Sciences, Khalsa University, Amritsar, Punjab, India
  6. Assistant Professor,, Department of Botany, Khalsa College (Autonomous), Amritsar, Punjab, India
  7. Assistant Professor,, Department of Biotechnology, Khalsa College (Autonomous), ., Amritsar, Punjab, India

Abstract

Curcumin, a compound isolated from turmeric, is used in the management of various diseases due to its extensive medicinal properties. Curcumin, the principal polyphenol isolated from Curcuma longa (turmeric), has garnered immense scientific interest for its extensive medicinal properties, including potent anti-inflammatory, antioxidant, and anticancer activities demonstrated in preclinical models. An expanding body of research indicates broad therapeutic promise in managing diverse pathologies, from
various cancers to chronic inflammatory, metabolic, and dermatological conditions. However, a significant paradox limits its clinical translation: this vast in vitro potential is almost completely nullified by catastrophic pharmacokinetic failures. This review deconstructs this “curcumin paradox.”An expanding body of research indicates that curcumin may hold promise as a therapeutic agent in the management of various dermatological conditions. It possesses anticancer activity by suppressing proliferation and metastasis and by promoting cell cycle arrest or apoptosis in various cancer cells. Despite all these benefits, the therapeutic application of curcumin in clinical medicine and its bioavailability are still impaired by its poor absorption and rapid metabolism. The combination of curcumin with novel delivery systems represents a highly promising area for future applied research.

Keywords: Anticancer, anti-arthritis, antioxidants, COVID-19, psoriasis, wound care

[This article belongs to Emerging Trends in Metabolites ]

How to cite this article:
Rajiv Kumar, Rajan Salwan., Nitish Sharma, Arshdeep Singh, Diksha Kumari, Rajbir Singh, mukesh chander. Anticancer Potential and Other Therapeutic Activities of Curcumin & Its Derivatives. Emerging Trends in Metabolites. 2026; 03(01):19-28.
How to cite this URL:
Rajiv Kumar, Rajan Salwan., Nitish Sharma, Arshdeep Singh, Diksha Kumari, Rajbir Singh, mukesh chander. Anticancer Potential and Other Therapeutic Activities of Curcumin & Its Derivatives. Emerging Trends in Metabolites. 2026; 03(01):19-28. Available from: https://journals.stmjournals.com/etm/article=2026/view=239102


References

1. Borik RM, Fawzy NM, Abu-bakr SM, Aly MS. Docking studies of novel heterocyclic derivatives obtained via reactions involving curcumin. Molecules. 2018;23:1398.
2. Chander M. Fungal-derived nutraceuticals & bioactive compounds with physiotherapeutic and health-promoting properties: A comprehensive review. Int J Fungi. 2025;2(2):1-9.
3. Damalas CA. Potential uses of turmeric (Curcuma longa) products as alternative means of pest management in crop production. Plant Omics. 2011;4:136-141.
4. Rai M, Pandit R, Gaikwad S, Yadav A, Gade A. Potential applications of curcumin and curcumin nanoparticles: From traditional therapeutics to modern nanomedicine. Nanotechnol Rev. 2015;4:161-172.
5. Nawaz A, Khan GM, Hussain A, Ahmad AA, Khan A. Curcumin: A natural product of biological importance. Gomal Univ J Res. 2011;27:7-14.
6. Ding L, Ma S, Lou H, Sun L, Ji M. Synthesis and biological evaluation of curcumin derivatives with water-soluble groups as potential antitumor agents. Molecules. 2015;20:21501-21514.
7. Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, et al. Dose-escalation and pharmacokinetic study of nanoparticle curcumin in healthy volunteers. Cancer Chemother Pharm. 2012;69:65-70.
8. Mahal A, Wu P, Jiang ZH, Wei X. Synthesis and cytotoxic activity of novel tetrahydrocurcumin derivatives bearing pyrazole moiety. Nat Prod Bioprospect. 2017;7:461-469.
9. Tripathi A, Misra K. Designing and development of novel curcumin analogues as inhibitors of breast cancer stem cell growth. Chem Eng Trans. 2016;49:79-84.
10. Vallianou NC, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015;35:645-651.
11. Beevers CS, Huang S. Pharmacological and clinical properties of curcumin. Bot Targets Ther. 2011;1:5-18.
12. Grynkiewicz G, Slifirski P. Curcumin and curcuminoids in quest for medicinal status. Acta Biochim Pol. 2012;59:201-212.
13. Hackler L Jr, Isvari B, Gyuris M, Sipos P, Fábián G, Molnár E, et al. Curcumin analog C-150 shows potent anticancer activity in vitro and in vivo. PLoS ONE. 2016;11:e0149832.
14. Zhang J, Feng Z, Wang C, Zhou H, Liu W, Kanchana K, et al. Curcumin derivative WZ35 suppresses colon cancer progression. Am J Cancer Res. 2017;7:275-288.
15. Liu Y, Zhou J, Hu Y, Wang J, Yuan C. Curcumin inhibits growth of human breast cancer cells via demethylation of DLC1 promoter. Mol Cell Biochem. 2017;425:47-58.
16. Pröhl M, Schubert US, Weigand W, Gottschaldt M. Metal complexes of curcumin derivatives for imaging and anticancer therapy. Coord Chem Rev. 2016;307:32-44.
17. Kumar AP, Garcia GE, Ghosh R, Rajnarayanan RV, Alworth WL, Slaga TJ. Curcumin derivative targeting Akt/NF-κB signaling pathway. Neoplasia. 2003;5:255-266.
18. Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, et al. Curcumin in liver diseases: Cellular mechanisms and clinical perspective. Nutrients. 2018;10:855.
19. Singh Khasla KP, Tierra M. The Way of Ayurvedic Herbs. Twin Lakes (WI): Lotus Press; 2008.
20. Skenderi G. Herbal Vade Mecum. Rutherford (NJ): Herbacy Press; 2003.
21. Vaughn AR, Branum A, Sivamani RK. Effects of turmeric on skin health: Systematic review. Phytother Res. 2016;30:1243-1264.
22. McClements DJ, Li F, Xiao H. Nutraceutical bioavailability classification scheme. Annu Rev Food Sci Technol. 2015.
23. Prasad S, Tyagi AK, Aggarwal BB. Delivery, bioavailability and metabolism of curcumin. Cancer Res Treat. 2014;46:2-18.
24. Hassaninasab A, Hashimoto Y, Tomita-Yokotani K, Kobayashi M. Curcumin metabolic pathway discovery. Proc Natl Acad Sci USA. 2011;108:6615-6620.

25. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16:259-265.
26. Aggarwal BB, Sung B. Pharmacological basis for curcumin in chronic diseases. Trends Pharmacol Sci. 2009;30:85-94.
27. Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin. J Agric Food Chem. 2011;59:9280-9289.
28. Yang C, Su X, Liu A, Zhang L, Yu A, Xi Y, et al. Advances in clinical study of curcumin. Curr Pharm Des. 2013;19:1966-1973.

29. Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, et al. Curcumin- loaded PLGA nanoparticles enhance bioactivity and bioavailability. Biochem Pharmacol. 2010;79:330-338.
30. Aggarwal BB. Cyclodextrin-complexed curcumin exhibits superior anti-inflammatory activity. Biochem Pharmacol. 2010;80:1021-1032.
31. Hou Y, Wang H, Zhang F, Sun F, Xin M, Li M, et al. Self-nano micellizing solid dispersion for oral delivery of curcumin. Int J Nanomedicine. 2019;14.
32. Yan F, Li H, Zhong Z, et al. Co-delivery of prednisolone and curcumin nanoparticles for rheumatoid arthritis. Int J Nanomedicine. 2019;14:9113-9125.
33. Manca ML, Lattuada D, Valenti D, et al. Curcumin-loaded hyalurosomes against inflammatory processes. Eur J Pharm Biopharm. 2019;136:84-92.
34. Chen B, Li H, Ou G, Ren L, Yang X, Zeng M. Curcumin attenuates MSU crystal-induced inflammation. Arthritis Res Ther. 2019;21:193.
35. Chander M, Paul M. Therapeutic & diagnostic applications of biosurfactants of microbial origin. Int J Multidiscip Res. 2025;7(1):1-25.

36. Li X, Xu DQ, Sun DY, Zhang T, He X, Xiao DM. Curcumin ameliorates monosodium urate- induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling. J Cell Biochem. 2019;120(4):6718-6728. doi: 10.1002/jcb.27969.
37. Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: A four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology. 2016;24(6):377-388. doi: 10.1007/s10787-016-0289.
38. Campbell NK, Fitzgerald HK, Malara A, et al. Naturally derived heme oxygenase 1 inducers attenuate inflammatory responses in human dendritic cells and T cells: Relevance for psoriasis treatment. Sci Rep. 2018;8(1):10287. doi : 10.1038/s41598-018-284886.

39. Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ. Encapsulation of curcumin in self- assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials. 2011;32:5906-5914.

40. Esmaili M, Ghaffari SM, Moosavi-Movahedi Z, Atri MS, Sharifizadeh A, Farhadi M, et al. Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application. LWT Food Sci Technol. 2011;44:2166-2172.
41. Lomis N, Westfall S, Farahdel L, Malhotra M, Shum-Tim D, Prakash S. Human serum albumin nanoparticles for use in cancer drug delivery: Process optimization and in vitro characterization. Nanomaterials. 2016;6:116.
42. Wong RSY. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.
43. Dilnawaz F, Singh A, Sahoo SK. Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Acta Biomater. 2012;8:704-719.

44. Ni Z, Xing F, Wang P, Cao G. Retracted: Synthesis, characterization and release of curcumin- intercalated Mg-Al layered double hydroxides. Appl Clay Sci. 2008;40:72-80.

45. Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, et al. Curcumin suppresses constitutive activation of AP-1 by down-regulation of Jund protein in HTLV-1-infected T-cell lines. Leuk Res. 2006;30:313-321.
46. Mishra A, Kumar R, Tyagi A, Kohaar I, Hedau S, Bharti AC, et al. Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. Ecancer. 2015;9:525.

47. Tomita M, et al. Retraction: Curcumin targets Akt cell survival signaling pathway in HTLV-I- infected T-cell lines. Cancer Sci. 2011;102:499.

48. Sharma E, Chander M, Kaur K. Diagnosis management & treatment of urinary tract infections: A recent perspective. Int J Curr Res Acad Rev. 2024;12(8):11-34. doi: 10.20546/ijcrar.2024.1208.002.
49. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, et al. Curcumin, a novel p300 CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyl-transferase-dependent chromatin transcription. J Biol Chem. 2004;279:51163-51171.
50. Simon RP, Robaa D, Alhalabi Z, Sippl W, Jung M. Katching-up on small molecule modulators of lysine acetyltransferases. J Med Chem. 2016;59:1249-1270.
51. Lu X, Deng Y, Yu D, Cao H, Wang L, Liu L, et al. Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer’s disease. PLoS One. 2014;9:e103067.
52. Cui L, Miao J, Cui L. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother. 2007;51:488-494.
53. Kutluay SB, Doroghazi J, Roemer ME, Triezenberg SJ. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology. 2008;373:239-247.
54. Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition. 2009;25:964-972.
55. Collins HM, Abdelghany MK, Messmer M, Yue B, Deeves SE, Kindle KB, et al. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer. 2013;13:37.
56. Kumar R, Salwan R, Chander M. The synthesis of medicinally important pharma molecules from carbohydrate building blocks. Int J Nov Res Dev. 2023;8(5):e138-148.
57. Chander M. Rauwolfia serpentina: A comprehensive phytochemical study of its bioactive metabolites. Emerg Trends Metab. 2024;1(2):14-40.
58. Chander M, Kaur J. Aquatic ecosystems: A review on prospecting of anticancer molecules from fungi & other microbes. Int J Fungi. 2024;1(2).
59. Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, et al. Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br J Nutr. 2016;115:2106-2113.
60. Okamura T, Kubo K. Turmeric pigment-containing chocolate with excellent flavor, texture, and hangover prevention/treatment properties. JP2009183206A. 2009.
61. Kwon HN. Functional noodles for relieving hangover and its manufacturing method. KR1314917B1. 2013.
62. Rezq ESA, Mansour MTA, Kumosani TA. Long acting conserved natural functional groups curcumin. WO2010057503A2. 2010.
63. Wang A, An X, Zhou Y. Application of curcumin to medicinal preparations for treating erectile dysfunction. CN101822656A. 2010.

64. Gertsch J. The metabolic plant feedback hypothesis: How plant secondary metabolites non- specifically impact human health. Planta Med. 2016;82:920-929.

65. Kang SK, Cha SH, Jeon HG. Curcumin-induced histone hypoacetylation enhances caspase-3- dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev. 2006;15:165-174.
66. Chen W, Bacanamwo M, Harrison DG. Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription. J Biol Chem. 2008;283:16293-16298.

Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 12/12/2025
Accepted 28/01/2026
Published 06/03/2026
Publication Time 84 Days
55

Login


My IP

PlumX Metrics